Transketolase (TKT) is a crucial enzyme in the non-oxidative branch of the pentose phosphate pathway (PPP), catalyzing the transfer of two-carbon units between various sugar phosphates. This enzyme connects glycolysis to the pentose phosphate pathway, enabling cells to generate ribose-5-phosphate for nucleotide biosynthesis while also producing NADPH for antioxidant systems. TKT dysfunction has been strongly implicated in Alzheimer's disease (AD) and other neurodegenerative conditions, making it a significant therapeutic target. [@martin2013]
Overview
TKT is a 623-amino acid homodimeric enzyme requiring thiamine pyrophosphate (TPP) as an essential cofactor. The enzyme catalyzes two reversible reactions: sedoheptulose-7-phosphate + glyceraldehyde-3-phosphate ⇌ erythrose-4-phosphate + fructose-6-phosphate, and ribose-5-phosphate + glyceraldehyde-3-phosphate ⇌ sedoheptulose-7-phosphate + fructose-6-phosphate. These reactions allow flexible redirection of carbon flux between glycolysis and nucleotide synthesis. [@gibson2013]
Protein Information
Structure and Mechanism
Domain Architecture
N-terminal domain: Dimerization interface
C-terminal domain: TPP binding and catalytic site
Active site: Contains conserved residues for TPP stabilization
Catalytic Mechanism
TPP activation: TPP forms ylide intermediate in active site
Aldehyde transfer: Accepts two-carbon unit from donor ketose
Isomerization: Intermediate rearranges within active site
Product release: Transfers two-carbon unit to acceptor aldose
TPP Dependence
TKT is highly sensitive to thiamine (vitamin B1) status:
TPP cofactor required for all catalytic activity
Thiamine deficiency directly impairs TKT function
Provides biochemical basis for thiamine supplementation therapy
TPP administration: Direct cofactor supplementation
Metabolic Modulation
PPP enhancers: Targeting PPP enzymes for neuroprotection
NADPH boosters: Supporting antioxidant capacity
Energy metabolism: Improving neuronal bioenergetics
Interaction Network
TKT interacts with:
Thiamine pyrophosphate (TPP) (cofactor)
Glyceraldehyde-3-phosphate (substrate)
Fructose-6-phosphate (substrate)
Sedoheptulose-7-phosphate (substrate)
Erythrose-4-phosphate (substrate)
Ribose-5-phosphate (product)
Glucose-6-phosphate dehydrogenase (PPP pathway)
6-Phosphogluconate dehydrogenase (PPP pathway)
Background
The study of Tkt Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Martin, M.A., et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23803211/)
[Gibson, G.E., et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24315776/)
[Mastroberardino, P.G., et al, (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19705452/)
[Unknown, Gibson, G.E., & Blass, J.P. (2007). Thiamine-dependent processes and the treatment of Alzheimer's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17315077/)
[Unknown, Baltrusch, S. (2021). The role of thiamine in the pathogenesis and progression of Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34202865/)
[Zhao, Y., et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22472250/)